The stress-vulnerability model how does stress impact on mental illness at the level of the brain and what are the consequences?

Psychiatria Danubina

Volumn 22, Issue 2, 2010, Pages 198-202

  Goh, Cindy ^c   Agius, Mark ^a,b  

^a South Essex Partnership University Foundation Trust ^*  (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Epigenetics; Hypothalamo pituitary axis; Schizophrenia; Stress; Vulnerability

Indexed keywords

BIPOLAR DISORDER; CELL LEVEL; CONFERENCE PAPER; DEPRESSION; DISEASE PREDISPOSITION; GENETICS; HUMAN; MENTAL DISEASE; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC TEST; SCHIZOPHRENIA; STRESS; STRESS VULNERABILITY MODEL;

ATROPHY; BRAIN; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDIVIDUALITY; MENTAL DISORDERS; METABOLIC SYNDROME X; MIND-BODY RELATIONS (METAPHYSICS); NEUROTRANSMITTER AGENTS; PITUITARY-ADRENAL SYSTEM; RISK FACTORS; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 77954356060     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Almeida JR et al: Reduced gray matter volume in ventral prefrontal cortex but not amygdale in bipolar disorder: significant effects of gender and trait anxiety. Psychiatry Res. 2009; 171:54-68.
2. Bernardo M, Canas F, Banegas JR, Casademont J, Riesgo Y & Varela C: On behalf of the RICAVA Study Group Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area.2009; Eur Psychiatry 24;431-41.
3. Craddock N, O'Donovan MC & Owen MJ: The genetics of schizophrenia and bipolar disorder: dissecting psychosis. Journal of Medical Genetics.2005; 42; 193-204. (Pubitemid 40380298)
4. Craddock N & Owen MJ: The beginning of the end for the Kraepelinian dichotomy. British Journal of Psychiatry 2005; 186(5); 364-366.
5. Duman RS, Heninger GR & Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry1997; 54:597-606.
6. Davidson RJ, Pizzagalli D, Nitschke JB & Putnam K: Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002 53:545-574.
7. Dzubur Kulenović A, Kucukalić A & Malec D: Changes in plasma lipid concentrations and risk of coronary artery disease in army veterans suffering from chronic post-traumatic stress disorder. Croat Med J.2008;49:506-14.
8. Fanselow MS: Contextual fear, gestalt memories, and the hippocampus. Behav Brain Res 2000; 110:73-81. (Pubitemid 30236293)
9. Felmingham K et al: Duration of post-traumatic stress disorder predicts hippocampal grey matter loss. Neuroreport. 2009; 20:1402-6.
10. Garner B et al.: Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis Biol Psychiatry 2005; 58:417-423.
11. Garner B, Chanen AM, Phillips L, Velakoulis D, Wood SJ, Jackson HJ, Pantelis C & McGorry PD: Pituitary volume in teenagers with first-presentation borderline personality disorder. Psychiatry Res. 2007 Dec 15;156:257-61.
12. Gould E, Tanapat P, Rydel T & Hastings N: Regulation of hippocampal neurogenesis in adulthood.Biol Psychiatry 2000; 48:715-720.
13. Herken H, Erdal M, Aydin N, Sengul C, Karadag F, Barlas O & Akin F:The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia. DNA Cell Biol. 2009;28:515-9.
14. Ho et al.: Association Between Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism and Progressive Brain Volume Changes in Schizophrenia Am. J. Psychiatry 2007; 164:1890-1899.
15. Jaracz J: The anatomy of depression in light of evidence from neuroimaging studies. Psychiatr Pol. 2008; 42:875-88.
16. Jovev M, Garner B, Phillips L, Velakoulis D, Wood SJ , Jackson HJ, Pantelis C, McGorry PD: Chanen AM.An MRI study of pituitary volume and parasuicidal behavior in teenagers with first-presentation borderline personality disorder. Psychiatry Res. 2008 Apr 15;162:273-7.
17. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR,Hamer DH & Murphy DL: Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region. Science 1996; 274: 1527.
18. Lorenzetti V et al.: Pituitary gland volume in currently depressed and remitted depressed patients. Psychiatry Res. 2009:172:55-60.
19. McGowan P et al: Epigenetic regulation of the glucocorticoid receptor in human brain associates with Childhood Abuse. Nature Neuroscience 2009; 12; 342-347.
20. Myint AM: Blood and CSF kynurenines and their clinical implications in major depressive disorders. Psychiatria Danubina 2009 Vol21 s2 ;S166.
21. Musselman DL, Evans DL & Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55:580-592.
22. Nestler EJ, Barrot M, DiLeone RJ, et al: Neurobiology of depression. Neuron 2002;34:13-25.
23. Pariante CM et al: Pituitary volume in psychosis. The British Journal of Psychiatry 2004.185: 5-10.
24. Reul JM & deKloet ER. J: Steroid Biochem 1986 24:269-272.
25. Richelson E: Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J Clin Psychiatry 2003; 64(Suppl 13):5-12.
26. Rogers MA et al.: Smaller amygdale volume and reduced anterior cingulated gray matter associated with history of post-traumatic stress disorder. Psychiatry Res. 2009;174:210-6.
27. Sheline YI, Wang PW, Gada MH, Csernansky JG & Vannier MW: Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93:3908-3913.
28. Squire LR & Knowlton BJ. In: Gazzaniga MS, ed. The New Cognitive Neurosciences; 2000:765-779.
29. Stahl SM: Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd ed. New York, NY: Cambridge University Press; 2000:187.
30. Sumich A et al.: Temporal Lobe Abnormalities in First-Episode Psychosis Am. J. Psychiatry 2002; 159:1232-1235.
31. Takahashi T, Malhi GS, Wood SJ, Walterfang M, Yücel M, Lorenzetti V, Soulsby B, Suzuki M, Velakoulis D & Pantelis C: Increased pituitary volume in patients with established bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33:1245-9.
32. Takahashi T, Walterfang M, Wood SJ, Kempton MJ, Jogia J, Lorenzetti V, Soulsby B, Suzuki M, Velakoulis D, Pantelis C & Frangou S: Pituitary volume in patients with bipolar disorder and their first-degree relatives. J Affect Disord. 2009 Dec 18.
33. Van der Plas EA et al: Amygdala volume correlates positively with fearfulness in normal healthy girls. Soc. Cogn Affect Neurosci. 2010 Feb11. [Eupub ahead of Print]
34. Verma SK, Subramaniam M, Liew A & Poon LY: Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry 2009; 70:997-1000.
35. Wakade CG et al.: Atypical neuroleptics stimulate neurogenesis in adult rat brainl Journal of Neuroscience Research 2002; 69; 72-79.
36. Weniger G, et al.: Reduced amygdale and hippocampus size in trauma-exposed women with borderline personality disorder and without post-traumatic stress disorder. J Psychiatry Neurosci. 2009;34:383-8.
37. Xiu P & Masad S:The role of distinctive orexin pathways in stress and reward mediated behaviours and their possible interplay. Psychiatria Danubina, 2009; Vol. 21, Suppl. 2; S256.
38. Zubin J and Spring B: Vulnerability; a new view of Schizophrenia. Journal of Abnormal Psychology 1977; 86;103-126.